XIGAMET XR 5/1000 TABLET

XIGAMET XR 5/1000 Tablet is a combination medication that contains two active ingredients: Dapagliflozin and Metformin. Dapagliflozin belongs to a class of drugs called sodium-glucose cotransporter 2 (SGLT2) inhibitors, while Metformin is a biguanide medication. This combination is used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels and improve glycemic control.

Uses:

1. Type 2 Diabetes Mellitus: XIGAMET XR 5/1000 Tablet is prescribed to individuals with type 2 diabetes mellitus who are unable to control their blood sugar levels adequately through diet and exercise alone. It works by reducing the amount of glucose reabsorbed by the kidneys and by decreasing the amount of glucose produced by the liver.
2. Glycemic Control: By lowering blood glucose levels, this medication helps to improve overall glycemic control in patients with type 2 diabetes, reducing the risk of diabetes-related complications.

Side Effects:

As with any medication, XIGAMET XR 5/1000 Tablet may cause some side effects. Not everyone will experience these side effects, but some common ones may include:

1. Urinary Tract Infections (UTIs): Dapagliflozin may increase the risk of UTIs, as it causes more glucose to be excreted in the urine, creating a more favorable environment for bacterial growth.
2. Genital Infections: Some individuals may experience genital yeast infections or itching due to the increased glucose levels in the genital area.
3. Hypoglycemia: While XIGAMET XR 5/1000 Tablet is not likely to cause hypoglycemia (low blood sugar) on its own, it can occur when used in combination with other diabetes medications like insulin or sulfonylureas.
4. Gastrointestinal Disturbances: Common gastrointestinal side effects may include nausea, vomiting, diarrhea, and abdominal discomfort.
5. Dehydration and Dizziness: Dapagliflozin can lead to increased urination, potentially causing dehydration and dizziness, especially in older adults.

It is essential to report any unusual or severe side effects to your healthcare provider.

When Not to Use:

1. Type 1 Diabetes: XIGAMET XR 5/1000 Tablet is not indicated for the treatment of type 1 diabetes, as it is not effective in managing insulin-dependent diabetes.
2. Diabetic Ketoacidosis (DKA): This medication should not be used in individuals with DKA, a severe complication of diabetes characterized by high blood ketone levels and acidosis.
3. Severe Kidney Impairment: XIGAMET XR 5/1000 Tablet should be used with caution or avoided in patients with severe kidney impairment or end-stage renal disease, as both dapagliflozin and metformin are excreted through the kidneys.
4. Hypersensitivity: Individuals with a known hypersensitivity to dapagliflozin or metformin should not use this combination medication.

Always follow your healthcare provider’s instructions regarding the proper use of XIGAMET XR 5/1000 Tablet. Inform them about any pre-existing medical conditions, medications, or allergies you may have to ensure safe and effective treatment for your diabetes management.